BP profits slide awaiting new CEO

Weather - Sydney 9°C

BP profits slide awaiting new CEO

ECONOMY 10.02.2026

BP profits slide awaiting new CEO / Photo: © AFP

British oil giant BP announced Tuesday an 86 percent slide in annual net profit, hit by lower crude prices and a huge write-down linked to its green energy transition.

Change text size:

Profit after tax dropped to $55 million last year from $381 million a year earlier, BP said in a statement.

The results come ahead of Meg O'Neill taking over as BP's chief executive in April, becoming the first woman to lead an oil major.

BP said the annual results included an impairment totalling around $4 billion linked to its "transition businesses in the gas and low carbon energy segment".

It added that its annual performance was "delivered against a weaker oil price environment".

Underlying earnings, which strip out some energy price movements and one-off charges, fell 16 percent to $7.5 billion last year.

Energy prices have been under pressure on concerns that US President Donald Trump's tariffs will crimp economic growth.

They dropped further last year as a result of higher output by OPEC+ nations and hopes of an end to the war in Ukraine, as Russia remains a major energy producer.

More recently, prices have risen as Trump ramped up military threats against Iran, but have since cooled on easing tensions between Washington and Tehran.

The international oil price benchmark, Brent North Sea crude, was steady Tuesday at $69 per barrel.

- New leadership -

BP's boardroom shakeup at the end of last year came with the company pivoting back to its more profitable oil and gas business, slashing clean energy investment after shelving targets on reducing carbon emissions.

Carol Howle has served as interim CEO since Murray Auchincloss unexpectedly stepped down in December.

"We look forward to Meg O'Neill joining as CEO in April as we accelerate our progress to build a simpler, stronger and more valuable BP for the future," Howle said in Tuesday's statement.

"We can and will do better for our shareholders," she added as the group suspended share buybacks.

That news hit BP's share price, which shed five percent in morning trading in London.

Weighing on the stock was also a poor fourth quarter, which showed net losses increasing 75 percent to $3.4 billion

"A move to cancel buybacks gives the incoming CEO a clean slate when she takes over," said Neil Wilson, an investor strategist at Saxo.

"It would also help it fulfil its commitment to slash debt, which remains stubbornly high above $22 billion, hardly moving at all last year," he added.

O'Neill, an American who spent 23 years working for ExxonMobil, is the first external candidate to be appointed CEO of BP in the group's 116-year history.

She has led Australian group Woodside Energy since April 2021.

BP, which is not alone among peers in scaling back climate targets, agreed in December to sell a majority stake in its Castrol lubricants business to US investment firm Stonepeak for $6 billion, as it seeks to cut debt.

British rival Shell last week said its net profit rose 11 percent last year as higher volumes and lower costs helped to offset falling oil and gas prices.

Profit after tax climbed to $17.84 billion in 2025 from $16.1 billion a year earlier.

N.Johns--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - BP profits slide awaiting new CEO